Find your next paid study

Actual pay is set by the research site.

Mayo ClinicNCT06891209

LupusFibromyalgia (FM)Chronic Widespread Pain

Evaluating the Feasibility and Efficacy of Emotional Awareness and Expression Therapy (EAET) on Fibromyalgia Outcomes in Patients With Systemic Lupus Erythematosus (SLE).

The goal of this clinical trial is to learn if a psychotherapy intervention works to relieve widespread pain in patients with lupus. The main questions it aims…

University of UtahNCT07282392

Actual pay is set by the research site.

Phase 2

A Phase II, Multicenter, Open-label, Non-comparative Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Osilodrostat in Children and Adolescent Patients With Cushing's Syndrome

Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent …

Cushing Syndrome

RECORDATI GROUPNCT03708900

~$75 – $3,000

Actual pay is set by the research site.

Sampling Therapeutic Effects and Progress in Cerebral Palsy (STEP-CP)

Cerebral palsy (CP) results from an early brain injury that can have cascading effects on the neuromuscular system and often results in life-long mobility impa…

Cerebral Palsy (CP)

Father Flanagan's Boys' HomeNCT07752030

~$10 – $1,050

Actual pay is set by the research site.

Peripheral Neuropathy With Type 2 DiabetesPeripheral Neuropathy Grade 2 or GreaterBalance+3 more

Wearable Sensory Prostheses to Improve Neuromuscular Coordination, Walking Function, and Real-World Physical Activity

The goal of this clinical trial is to investigate whether sensory stimulations from a neuroprosthesis device (Walkasins®) can increase physical activity and im…

RxFunction Inc.NCT07554443

~$10 – $1,050

Actual pay is set by the research site.

Risk Reduction BehaviorSuicide PreventionRisky Behavior+3 more

SAFEGUARD Level Up Study

This project will evaluate the effectiveness of Level Up: Boost Your Life Skills ("Level Up"), a strengths based, military-specific life skills training progra…

Uniformed Services University of the Health SciencesNCT07286955

Actual pay is set by the research site.

A Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of Vactosertib as a Single Agent in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma

MP-VAC-209 is a Phase I/II, open label, single arm, multi-center study to assess safety, tolerability, and antitumor activity of vactosertib as a single agent …

Osteosarcoma

MedPacto, Inc.NCT05588648

~$150 – $4,200

Actual pay is set by the research site.

Substance Use Disorder (SUD)mHealth

Harnessing mHealth to Support Loved Ones of Individuals in Recovery From Substance Use Disorders

Substance use disorders are highly prevalent. However, recovery from them is possible. The recovery process can benefit greatly from support from loved ones. L…

Rhode Island HospitalNCT07740395

Actual pay is set by the research site.

Obese IndividualsCentral Adiposity

Effects of Inorganic Nitrate Supplementation on Post-exercise Hypotension Response Following Acute Exercise in Young Adults With Elevated Body Mass Index and Blood Pressure

This study is examining whether acute inorganic nitrate supplementation in the form of beetroot juice, paired with an acute bout of exercise, affects blood pre…

University of VirginiaNCT07869472

Actual pay is set by the research site.

NSCLC Stage IVALK Fusion Protein Expression

Pilot Study of a Prophylactic Cancer Peptide Vaccine in Advanced ALK+ NSCLC

The purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients c…

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT05950139

~$150 – $3,000

Actual pay is set by the research site.

Mantle Cell LymphomaRefractory Lymphoma

A Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in Patients With Relapsed/Refractory and Previously Untreated Mantle Cell Lymphoma

This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab - as a possible treatment for relapsed or refrac…

~$150 – $4,500

Actual pay is set by the research site.

Austin I KimNCT04855695

Non-Small Cell Lung Cancer

A Phase I Open-label, Multi-dose, Dose Escalation and Dose Expansion Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

This is a Phase I, multicenter, open-label, dose escalation and dose expansion study to assess the safety and pharmacokinetic profile of PLB1004, a mono-anilin…